Apex Biotechnology (TPE:1733) Cash Flow for Dividends : NT$0 Mil (TTM As of Dec. 2024)

View and export this data going back to 2001. Start your Free Trial

What is Apex Biotechnology Cash Flow for Dividends?

Apex Biotechnology's cash flow for dividends for the three months ended in Dec. 2024 was NT$0 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Dec. 2024 was NT$0 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

Apex Biotechnology's annual payment of dividends increased from Dec. 2022 (NT$-130 Mil) to Dec. 2023 (NT$-140 Mil) but then declined from Dec. 2023 (NT$-140 Mil) to Dec. 2024 (NT$-110 Mil).

Apex Biotechnology Cash Flow for Dividends Historical Data

The historical data trend for Apex Biotechnology's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Apex Biotechnology Cash Flow for Dividends Chart

Apex Biotechnology Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Cash Flow for Dividends

Get a 7-Day Free Trial

-109.95

-109.32

-129.94

-139.93

-109.95

Apex Biotechnology Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Cash Flow for Dividends	Get a 7-Day Free Trial															-	-	-	-	-

Apex Biotechnology Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$0 Mil.

Apex Biotechnology Cash Flow for Dividends Related Terms

Thank you for viewing the detailed overview of Apex Biotechnology's Cash Flow for Dividends provided by GuruFocus.com. Please click on the following links to see related term pages.

Apex Biotechnology Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Apex Biotechnology Corp (TPE:1733) » Definitions » Cash Flow for Dividends

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.7, Li-Hsin 5th Road, Hsinchu Science Park, Hsinchu, TWN, 30078

Website

https://www.apexbio.com

Apex Biotechnology Corp engages mainly in the research, development, production, manufacturing, and selling of biochemical testing instruments and detection strips, and the trade of products and components relevant to the core business. Its products offer Diabetes Care, Home Diagnostics, and Point-of-Care Clinical and Laboratory. Its product offerings include Eclipse plus multipurpose analyzer, Glucosure HT blood glucose monitoring system, and HemoSmart GOLD hemoglobin screening system among others. Company operates in Taiwan, USA, Italy, Austria, China , Others. Majority of revenue is from USA.

Apex Biotechnology Headlines

No Headlines